With $35M investment in its flagship New York plant, Curia continues its busy summer of expansion

SourceFierce Pharma
Date Published08/19/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Curia
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Domestically, the work will be done:In-house
Capital investment ($):35
City reshored to:Rensselaer
State(s) reshored to:NY
If relevant, work nearshored to:-
Product(s) reshoredhigh-potency API
Find Reshoring Articles